With a 7.7% compound annual growth rate (CAGR) from 2023 to 2033, the global cell line development industry is projected to reach US$ 5.06 billion in 2023 and reach US$ 10.6 billion by 2033. The market was estimated to be worth US$ 4.7 billion in 2022.
The substantial growth of the cell line development market is predominantly attributed to the increasing adoption of bio-therapeutics for treating chronic diseases like arthritis, diabetes, and cancer.
Get a Sample Copy of the Report:
https://www.futuremarketinsigh....ts.com/reports/sampl
Gusto
Magkomento
Ibahagi
